Adverse event | N (%), tot = 140 patients | G3–4 N (%), tot = 140 patients |
---|---|---|
Cutaneous | 52 (37) | 5 (4) |
 Pruritus | 22 (16) | 3 (2) |
 Rash | 24 (17) | 2 (1) |
 Vitiligo | 6 (4) | 0 |
Gastrointestinal | 30 (21) | 21 (15) |
 Diarrhea | 21 (15) | 19 (14) |
 Pancreatitis or lipase/amylase increase | 5 (4) | 2 (1) |
 Nausea/vomit | 3 (2) | 0 |
 Constipation | 1 (1) | 0 |
Constitutional symptoms | 21 (15) | 0 |
 Fatigue | 13 (9) | 0 |
 Fever | 7 (5) | 0 |
 Headache | 1 (1) | 0 |
Endocrine disorders | 12 (9) | 11 (8) |
 Hypophysitis | 10 (7) | 10 (7) |
 Thyroiditis | 1 (1) | 0 |
 Hyperglycemia | 1 (1) | 1 (1) |
Other | 9 (6) | 1 (1) |
 Arthralgia | 5 (4) | 1 (1) |
 Hepatotoxicity | 2 (1) | 0 |
 Anemia | 1 (1) | 0 |
 Posterior uveitis | 1 (1) | 0 |